Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Interféron bêta")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 2491

  • Page / 100
Export

Selection :

  • and

An alternative regulatory pathway of the acute phase response: the role of fibroblast-derived interferon-β2KOJ, A; GORDON, A. H; GAULDIE, J et al.Experientia. 1988, Vol 44, Num 1, pp 9-10, issn 0014-4754Article

Interféron bêta et thyroïde = Beta interferon and thyroidLAARIBI, O; MARRAKCHI, A; MSYAH, L et al.Annales d'endocrinologie. 2006, Vol 67, Num 1, pp 42-44, issn 0003-4266, 3 p.Article

Cardiac arrhythmia induced by interferon beta-1aKASTALLI, Sarrah; SIHEM EL AÏDLI; MOURALI, Sami et al.Fundamental & clinical pharmacology. 2012, Vol 26, Num 2, pp 207-209, issn 0767-3981, 3 p.Article

Human fibroblast interferon in cervical and vulvar intraepithelial neoplasia associated with papilloma virus infectionDE PALO, G; STEFANON, B; RILKE, F et al.International journal of tissue reactions. 1984, Vol 6, Num 6, pp 523-527, issn 0250-0868Article

Effect of human fibroblast interferon on the antiviral activity of mammalian cells treated with bleomycin, vincristine, or mitomycin C = Effet de l'interféron de fibroblastes humains sur l'activité antivirale des cellules de mammifères traitées par la bléomycine, la vincristine ou la mitomycine CSUHADOLNIK, R. J; SAWADA, Y; FLICK, M. B et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5462-5466, issn 0008-5472Article

Bioequivalence of Two Subcutaneous Pharmaceutical Products of Interferon Beta 1aDI GIROLAMO, Guillermo; KAUFFMAN, Marcelo A; DIEZ, Roberto A et al.Arzneimittel-Forschung. 2008, Vol 58, Num 4, pp 193-198, issn 0004-4172, 6 p.Article

Immunogenicity of biopharmaceuticals. The european perspectiveSCHELLEKENS, H; CASADEVALL, N.Developments in biologicals. 2003, Vol 112, pp 23-28, issn 1424-6074, 6 p.Article

Potentiation of the cell growth inhibitory effect of β interferon by mopidamoleBIDDLE, W; LEONG, S. S; HOROSZEWICZ, J et al.Proceedings of the Society for Experimental Biology and Medicine. 1984, Vol 177, Num 3, pp 487-490, issn 0037-9727Article

Enhancement of actinomycin D- and cis-diamminedichloroplatinum(II)-induced killing of human fibroblasts by human β-interferon = Augmentation de la destruction des fibroblastes humains induite par l'actinomycine D et le cis-diamminedichloroplatinum (II) par l'interféron bêta humainINOUE, M; TAN, Y. H.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5484-5488, issn 0008-5472Article

Interférons Bêta et sclérose en plaques = Interferons beta and multiple sclerosisLa Revue Prescrire. 2002, Vol 22, Num 225, issn 0247-7750, p. 136Article

Réduction des réactions cutanées aux points d'injection avec deux auto-injecteurs chez des patients ayant une sclérose en plaques rémittente débutant un traitement par interféron bêta-1b : étude randomisée en cross-over = Reduction of injection site reactions in multiple sclerosis (MS) patients newly started on interferon beta 1 b therapy with two different devicesBROCHET, B; LEMAIRE, G; BEDDIAF, A et al.Revue neurologique (Paris). 2006, Vol 162, Num 6-7, pp 735-740, issn 0035-3787, 6 p.Article

The interferon-interleukin 1 connectionBILLIAU, A.Interferon. 1987, Num 9, pp 91-111, issn 0276-1076Article

Activation of the beta interferon promoter by paramyxoviruses in the absence of virus protein synthesisKILLIP, M. J; YOUNG, D. F; PRECIOUS, B. L et al.Journal of general virology. 2012, Vol 93, pp 299-307, issn 0022-1317, 9 p., 2Article

Inhibition of Endogenous Interferon Beta by Neutralizing Antibodies Against Recombinant Interferon BetaSOMINANDA, Ajith; LUNDKVIST, Malin; FOGDELL-HAHN, Anna et al.Archives of neurology (Chicago). 2010, Vol 67, Num 9, pp 1095-1101, issn 0003-9942, 7 p.Article

Interferon beta-1b in secondary progressive MS: Results from a 3-year controlled studyNeurology. 2004, Vol 63, Num 10, pp 1788-1795, issn 0028-3878, 8 p.Article

Effect of neutralizing antibodies on biomarker responses to interferon beta: The INSIGHT studyPACHNER, Andrew R; WARTH, John D; PACE, Amy et al.Neurology. 2009, Vol 73, Num 18, pp 1493-1500, issn 0028-3878, 8 p.Article

Model-based analysis of interferon-β induced signaling pathwaySMIEJA, Jaroslaw; JAMALUDDIN, Mohammad; BRASIER, Allan R et al.Bioinformatics (Oxford. Print). 2008, Vol 24, Num 20, pp 2363-2369, issn 1367-4803, 7 p.Article

Interferon beta-1b in secondary progressive MS: A combined analysis of the two trialsKAPPOS, L; WEINSHENKER, B; POZZILLI, C et al.Neurology. 2004, Vol 63, Num 10, pp 1779-1787, issn 0028-3878, 9 p.Article

Simultaneous in situ detection of beta-interferon mRNA and DNA in the same cellTANG, F. J. K; TS'O, P. O. P; LESKO, S. A et al.The Journal of histochemistry and cytochemistry. 1989, Vol 37, Num 5, pp 697-701, issn 0022-1554, 5 p.Article

US FDA-approved disease-modifying treatments for multiple sclerosis: Review of adverse effect profilesGALETTA, Steven L; MARKOWITZ, Clyde.CNS drugs. 2005, Vol 19, Num 3, pp 239-252, issn 1172-7047, 14 p.Article

Rapid enhancement of β2-interferon/B-cell differentiation factor BSF-2 gene expression in human fibroblasts by diacylglycerols and the calcium ionophore A23187SEHGAL, P. B; WALTHER, Z; TAMM, I et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 11, pp 3663-3667, issn 0027-8424Article

Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of β2 interferon by human fibroblastsHELFGOTT, D. C; MAY, L. T; STHOEGER, Z et al.The Journal of experimental medicine. 1987, Vol 166, Num 5, pp 1300-1309, issn 0022-1007Article

Induction of β2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferationKOHASE, M; HENRIKSEN-DESTEFANO, D; MAY, L. T et al.Cell (Cambridge). 1986, Vol 45, Num 5, pp 659-666, issn 0092-8674Article

Appearance and disappearance of neutralizing antibodies during interferon-beta therapySORENSEN, P. Soelberg; KOCH-HENRIKSEN, N; ROSS, C et al.Neurology. 2005, Vol 65, Num 1, pp 33-39, issn 0028-3878, 7 p.Article

CHO Cells Adapted to Hypothermic Growth Produce High Yields of Recombinant β-InterferonSUNLEY, Kevin; THARMALINGAM, Tharmala; BUTLER, Michael et al.Biotechnology progress. 2008, Vol 24, Num 4, pp 898-906, issn 8756-7938, 9 p.Article

  • Page / 100